Key result
Transcriptome analysis of cMyBP-C-null mice revealed prehypertrophic upregulation of Xirp2 (2.87-fold) and Zbtb16 (2.40-fold), suggesting early dysregulation of mechanosensing pathways in HCM.
Population
cMyBP-C-/- mouse model of hypertrophic cardiomyopathy (HCM) and wild type (WT) mice (n=7 each)
Comparison
Microarray analysis on left ventricles at… vs Wild type (WT) mice
Design
Preclinical
Follow-up
Postnatal day 9
Authors
Loading...
Hypothesis-generating in cMyBP-C-null mice; extends preclinical insights into early HCM mechanosensing but requires human validation before clinical relevance.
Transcriptome analysis in a mouse model of HCM reveals early prehypertrophic dysregulation of mechanosensing pathways and potassium channels, specifically highlighting Xirp2 and Zbtb16.
Farrell et al. (2018) studied Hypertrophic cardiomyopathy (HCM) (n=28). cMyBP-C genetic ablation (cMyBP-C-/-) vs. Wild-type (WT) littermates was evaluated on Differential gene expression (transcriptome analysis). Transcriptome analysis of cMyBP-C-null mice revealed prehypertrophic upregulation of Xirp2 (2.87-fold) and Zbtb16 (2.40-fold), suggesting early dysregulation of mechanosensing pathways in HCM.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: